Skip to main content
SpringerLink
Log in

Influence of Antiplatelet Drugs on Platelet-Surface Interactions

  • Chapter
Thrombosis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 102))

Abstract

Platelet aggregates are important in the thromboembolic complications of prosthetic devices, and drugs that alter platelet function have shown promise in clinical trials. Results with these drugs have increased insight into the interaction of platelets with artificial materials, particularly when the clinical experience has been correlated with the results of in vitro models.

In a bead column/surface contact model, the characteristic interactions of platelets with artificial surfaces resemble effects of adding thrombin or ADP to platelet-rich plasma. Anti-inflammatory agents and other antiplatelet drugs inhibit these reactions. Results in an in vivo model, survival of 51Cr-labeled platelets in sheep bearing arteriovenous shunts of test materials, correlate well with results in the in vitro model. Findings in these model systems indicate that the initial events upon contact of a surface with plasma proteins persistently influence the long-term behavior of that surface toward blood.

A review of clinical studies discusses the effect of antiplatelet drugs on platelet survival and also on thrombotic complications of heart valve replacement and other conditions employing prosthetic devices.

Supported by grants #HL14322, #HL20079 and #HL11414 from the National Heart, Lung and Blood Institute, National Institutes of Health. Original experiments reported here were performed in collaboration with J. N. Lindon and D. Brier.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berger S, Salzman EW: Thromboembolic complications of prosthetic devices. In PROGRESS IN HEMOSTASIS AND THROMBOSIS, Vol. II, edited by Spaet TH. New York, Grune and Stratton, Inc., 1974, p. 273.

    Google Scholar 

  2. Salzman EW: Blood platelets: Their behavior with respect to extracorporeal membrane oxygenation. In ARTIFICIAL LUNGS FOR ACUTE RESPIRATORY FAILURE, edited by Zapol WM, Qvist J. Washington D.C., Hemisphere Corp., 1976, p. 105.

    Google Scholar 

  3. Salzman EW: Nonthrombogenic surfaces: Critical review. BLOOD 38: 509–523, 1971.

    PubMed  CAS  Google Scholar 

  4. Mason RG: The interaction of blood hemostatic elements with artificial surfaces. In PROGRESS IN HEMOSTASIS AND THROMBOSIS, Vol. 1, edited by Spaet TH. New York, Grune and Stratton, 1972, p. 141.

    Google Scholar 

  5. Scarborough DE: The pathogenesis of thrombosis in artificial organs and vessels. CURR TOP PATHOL 54: 95, 1971.

    Google Scholar 

  6. Leonard EF, Friedman LI: Thrombogenesis on artificial surfaces: A flow reactor problem. CHEM ENG PROGR SYMP SER 66: 59–71, 1970.

    CAS  Google Scholar 

  7. Bruck SD (Ed): BLOOD COMPATIBLE SYNTHETIC POLYMERS: AN INTRODUCTION. Springfield, Mo., Charles C Thomas Publishers, 1974.

    Google Scholar 

  8. Verstraete M: Are agents affecting platelet functions clinically useful? AM J MED 61: 897–914, 1976.

    Article  PubMed  CAS  Google Scholar 

  9. Genton E, Gent M, Hirsh J, Harker LA: Platelet-inhibiting drugs in the prevention of clinical thrombotic disease. N ENGL J MED 293:1174–1178, 1236–1240, 1296–1300, 1975.

    Google Scholar 

  10. Weiss HJ: Antiplatelet drugs–A new pharmacologic approach to the prevention of thrombosis. AM HEART J 92: 86–102, 1976.

    Article  PubMed  CAS  Google Scholar 

  11. Salzman EW, Lindon J, Brier D, Merrill EW: Surface induced platelet adhesion, aggregation, and release. PROC NY ACAD SCI 283: 114–127, 1977.

    Article  CAS  Google Scholar 

  12. Salzman EW, Lindon JN, Rodvien R: Cyclic AMP in human blood platelets. Relation to platelet prostaglandin synthesis induced by centrifugation or surface contact. J CYCLIC NUCLEOTIDE RES 2: 25–37, 1976.

    PubMed  CAS  Google Scholar 

  13. CazenaveJ-P, Packham MA, Guccione MA, Mustard JF: Inhibition of platelet adherence to a collagen-coated surface by non-steroidal anti-inflammatory drugs, pyrimido-pyrimidine and tricyclic compounds, and lidocaine. J LAB CLIN MED 83: 797–806, 1974.

    PubMed  CAS  Google Scholar 

  14. Ali M, McDonald JWD: Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. J LAB CLIN MED 89: 868–875, 1977.

    PubMed  CAS  Google Scholar 

  15. Salzman EW: Cyclic AMP and platelet function. N ENGL J MED 286: 358–363, 1972.

    Article  PubMed  CAS  Google Scholar 

  16. Salzman EW, Levine L: Cyclic 3’, 5’-adenosine monophosphate in human blood platelets: II. Effect of N6–2’-0-dibutyryl cyclic 3’, 5’-adenosine monophosphate on platelet function. J CLIN INVEST 50: 131–141, 1971.

    Article  PubMed  CAS  Google Scholar 

  17. Wilner GD, Casarella WJ, Fenoglio C, Baier RE: In vivo fibrinopeptide a generation induced by angiographic catheters. THROMB HAEMOSTAS 38: 73, 1977.

    Google Scholar 

  18. Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. N ENGL J MED 287: 999–1005, 1972.

    Article  PubMed  CAS  Google Scholar 

  19. Steele PP, Weily HS, Davies H, Genton E: Platelet function studies in coronary artery disease. CIRCULATION 48: 1194–1200, 1973.

    Article  PubMed  CAS  Google Scholar 

  20. Steele PP, Weily HS, Genton E: Platelet survival and adhesiveness in recurrent venous thrombosis. N ENGL J MED 288: 1148–1152, 1973.

    Article  PubMed  CAS  Google Scholar 

  21. Coe N, Collins R, Jagoda A, Brier D, Lindon J, Merrill E, Cohen R, Salzman E: In vivo assessment of thromboresistant materials by determination of platelet survival. THROMB HAEMOSTAS 38: 204, 1977.

    Google Scholar 

  22. Vroman L, Adams AL: Identification of rapid changes at plasmasolid interfaces. J BIOMED MATER RES 3: 43–67, 1969.

    Article  PubMed  CAS  Google Scholar 

  23. Dutton RC, Webber AJ, Johnson SA, Baier RE: Microstructure of initial thrombus formation on foreign materials. J BIOMED MATER RES 3: 13–23, 1969.

    Article  PubMed  CAS  Google Scholar 

  24. Lyman DJ, Brash JL, Chaikin SW, Klein KG, Carini M: Effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. II. Protein and platelet interaction with polymer surfaces. TRANS AM SOC ARTIF INTERN ORGANS 14: 250–255, 1968.

    PubMed  CAS  Google Scholar 

  25. Scarborough DE, Mason RG, Dalldorf FG, Brinkhous KM: Morphological manifestations of blood-solid interfacial reactions. LAB INVEST 20: 164–169, 1969.

    PubMed  CAS  Google Scholar 

  26. Packham MA, Evans G, Glynn MF, Mustard JF: Effect of plasma proteins on the interaction of platelets with glass surfaces. J LAB CLIN MED 73: 686–697, 1969.

    PubMed  CAS  Google Scholar 

  27. Salzman EW, Merrill EW, Binder A, Wolf CF, Ashford TP, Austen WG: Protein-platelet interaction on heparinized surfaces. J BIOMED MATER RES 3: 69–81, 1969.

    Article  PubMed  CAS  Google Scholar 

  28. Zucker MB, Vroman L: Platelet adhesion induced by fibrinogen adsorbed onto glass. PROC SOC EXP BIOL MED 131: 318–320, 1969.

    PubMed  CAS  Google Scholar 

  29. Salzman EW: Thromboembolic complications of cardiac and vascular prostheses. In SURGERY OF THE CHEST, edited by Sabiston DC, Spencer FG. Philadelphia, W.B. Saunders Co., 1974, p. 1220.

    Google Scholar 

  30. Duvoisin GE, Brandenburg RO, McGoon DC: Factors affecting thromboembolism associated with prosthetic heart valves. CIRCULATION 35 (Suppl 1): 70–76, 1967.

    Article  Google Scholar 

  31. Sullivan JM, Harken DE, Gorlin R: Pharmacologic control of thromboembolic complications of cardiac valve replacement. N ENGL J MED 279: 576–580, 1968.

    Article  PubMed  CAS  Google Scholar 

  32. Sullivan JM, Harken DE, Gorlin R: Effect of dipyridamole on the incidence of arterial emboli after cardiac valve replacement. CIRCULATION 39 (Suppl 1): 149, 1969.

    Article  Google Scholar 

  33. Stuart RK, McDonald JW, Ahuja SP, Coles JC: Platelet survival in patients with prosthetic heart valves. AM J CARDIOL 33: 840–844, 1974.

    Article  PubMed  CAS  Google Scholar 

  34. Dale J, Myhre E, Storstein O, Stormorken H, Efskind L: Prevention of arterial thromboembolism with acetylsalicyclic acid. AM HEART J 94: 101–111, 1977.

    Article  PubMed  CAS  Google Scholar 

  35. Altman R, Boullon F, Rouvíer J, Rada R, DeFuenta L, Favaloro R: Aspirin and prophylaxis of thromboembolic complications in patients with, substitute heart valves. J THORAC CARDIOVASC SURG 72: 127–129, 1976.

    PubMed  CAS  Google Scholar 

  36. Taguchi K, Matsumura H, Washizu T, Hírao M, Kato K, Kato E, Mochizuki T, Takamura K, Mashimo I, Morifuji K, Nakagaki M, Suma T: Effect of athrombogenic therapy, especially high dose therapy dipyridamole, after prosthetic valve replacement. J CARDIOVASC SURG 16: 8–15, 1975.

    CAS  Google Scholar 

  37. Björk V, Henz A: Management of thrombo-embolism after aortic valve replacement with the Bjork-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole–acetylsalicyclic acid. Surgical treatment of prosthetic thrombosis. SCAND J THORAC CARDIOVASC SURG 9: 183–191, 1975.

    Article  PubMed  Google Scholar 

  38. Weily HS, Genton E: Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. CIRCULATION 42 (Suppl 3): 205, 1970.

    Google Scholar 

  39. Weily HS, Steele PP, Davies H, Pappas G, Genton E: Platelet survival in patients with substitute heart valves. N ENGL J MED 290: 534–537, 1974.

    Article  PubMed  CAS  Google Scholar 

  40. Steele P, Genton E: Thromboembolism and platelet survival time before and after valve surgery. ADV CARDIOL 17: 189–198, 1976.

    PubMed  CAS  Google Scholar 

  41. Arrants JE, Hariston P, Lee WH, Jr.: Use of dipyridamole (persantine) in preventing thromboembolism following valve replacement. CHEST 58: 275, 1970.

    Google Scholar 

  42. Meyer JS, Charney JZ, Rivera VM, Mathew NT: Cerebral embolization: Prospective clinical analysis of 42 cases. STROKE 2: 541–554, 1971.

    Article  PubMed  CAS  Google Scholar 

  43. Rabello C, Rivas JA, Rocha F et aZ.: Estudo da açâo de Dipiridamol na evoluçâo de pacientes submetiedos â substitui çao de prbteses valvares. REV BRAS CLIN TER 2: 95, 1973.

    Google Scholar 

  44. Moriau M, Ferrant A, Beys C, Hurlet A, Chalant C, Ponlot R, Jaumain P, Goenen M, Masure R: Evaluation of the antithrombotic properties of suloctidil in patients with substitute heart valves. THROMB HAEMOSTAS 38: 96, 1977.

    Google Scholar 

  45. Siegelman SS, Caplan LH, Annes GP: Complications of catheter angiography. Study with oscillometry and “pullout” angiograms. RADIOLOGY 91: 251–253, 1968.

    PubMed  CAS  Google Scholar 

  46. Walker WJ, Mundall SL, Broderick HG, Prasad B, Kim J, Ravi JM: Systemic heparinization for femoral percutaneous coronary arteriography. N ENGL J MED 288: 826–828, 1973.

    Article  PubMed  CAS  Google Scholar 

  47. Eyer KM: Complications of transfemoral coronary arteriography and their prevention using heparin. AM HEART J 86: 428, 1973.

    Article  PubMed  CAS  Google Scholar 

  48. Hynes KM, Gau GT, Rutherford BD, Kazmier FJ, Frye RL: Effect of aspirin on brachial artery occlusion following brachial arteriotomy for coronary arteriography. CIRCULATION 47: 554–557, 1973.

    Article  PubMed  CAS  Google Scholar 

  49. Freed MD, Rosenthal A, Fyler D: Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin. AM HEART J 87: 283–286, 1974.

    Article  PubMed  CAS  Google Scholar 

  50. Jacobsson B: Use of dextran for prophylaxis against thromboembolic complication in arterial catheterization. ACTA CHIR SCAND (Suppl) 387: 103, 1968.

    CAS  Google Scholar 

  51. Evans G, Irvine WT: Long-term arterial-graft patency in relation to platelet adhesiveness, biochemical factors and anticoagulant therapy. LANCET 2: 353–355, 1966.

    Article  PubMed  CAS  Google Scholar 

  52. Slichter SJ, Harker L, Sauvage L: Platelet consumption as a measure of endothelialization of aorta-femoral grafts. PROC AM SOC HEMATOL, Florida, 1972, p. 46.

    Google Scholar 

  53. Blakely JA, Pogoriler G: A prospective trial of sulfinpyrazone after peripheral vascular surgery. THRONE HAEMOSTAS 38: 238, 1977.

    Google Scholar 

  54. Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M: Arteriovenous-shunt thrombosis: Prevention by sulfinpyrazone. N ENGL J MED 290: 304–306, 1974.

    Article  PubMed  CAS  Google Scholar 

  55. Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M: The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. CIRCULATION 52: 497–499, 1975.

    Article  PubMed  CAS  Google Scholar 

  56. Andrassy K, Ritz E, Schoeffner W, Hahn G, Walter K: The influence of acetylsalicyclic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients. KLIN WOCHENSCHR 49: 166–167, 1971.

    Article  PubMed  CAS  Google Scholar 

  57. Stuart M, Stockman J, Murphy S, Schut L, Ames M, Urmson J, Oski F: Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: Results of preliminary attempts at correction. J PEDIATR 80: 21–25, 1972.

    Article  PubMed  CAS  Google Scholar 

  58. Gralnick HR, Fischer RD: The hemostatic response to open-heart operations. J THORAC CARDIOVASC SURG 61: 909–915, 1971.

    PubMed  CAS  Google Scholar 

  59. Heiden D, Mielke CH, Rodvien R, Hill JD: Platelets, hemostasis and thromboembolism during treatment of acute respiratory insufficiency with extracorporeal membrane oxygenation. J THORAC CARDIOVASC SURG 70: 644–655, 1975.

    PubMed  CAS  Google Scholar 

  60. Backmann F, McKenna R, Cole ER, Najafi H: The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J THORAC CARDIOVASC SURG 70: 76–85, 1975.

    Google Scholar 

  61. Bick RL: Alterations of hemostasis associated with cardiopulmonary bypass: Pathophysiology, prevention, diagnosis, and management. SEMIN THROMB HEMOSTAS 3: 59–82, 1976.

    CAS  Google Scholar 

  62. Harbury CB, Galvan CA: A bleeding diathesis associated with a platelet storage pool deficiency acquired during cardiopulmonary bypass surgery. THROMB HAEMOSTAS 38: 237, 1977.

    Google Scholar 

  63. Boyd AD, Engleman RM, Beaudet RL, Lackner H: Disseminated intravascular coagulation following extracorporeal circulation. J THORAC CARDIOVASC SURG 64: 685–693, 1972.

    PubMed  CAS  Google Scholar 

  64. Allardyce DB, Yoshida SH, Ashmore PG: The importance of micro-embolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump oxygenator. J THORAC CARDIOVASC SURG 52: 706–715, 1966.

    PubMed  CAS  Google Scholar 

  65. Ashmore PG, Svitek V, Ambrose P: The incidence and effects of particulate aggregation and microembolism in pump-oxygenator systems. J THORAC CARDIOVASC SURG 55: 691–697, 1968.

    PubMed  CAS  Google Scholar 

  66. Rittenhouse EA, Hessel EA, Ito CS, Merendino KA: Use of Persantin to reduce microaggregation in the pump oxygenator. SURG FORUM 21: 142–144, 1970.

    PubMed  CAS  Google Scholar 

  67. Becker RM, Smith MR, Dobell ARC: Effect of dipyridamole on platelet function in cardiopulmonary bypass in pigs. SURG FORUM 23: 169, 1972.

    PubMed  CAS  Google Scholar 

  68. Mielke CH, Hill JD, Geroode F: Drug influence on platelet loss during extracorporeal circulation. J THORAC CARDIOVASC SURG 66: 845–854, 1973.

    PubMed  Google Scholar 

  69. Long DM, Todd DB, Indeglia RA, Varco RL, Lillehei CW: Clinical use of dextra-40 in extracorporeal circulation–A summary of 5 years’ experience. TRANSFUSION 6: 401–403, 1966.

    Article  PubMed  Google Scholar 

  70. Bloom S, Zapol W, Wonders T, Berger S, Salzman E: Platelet destruction during 24 hour membrane lung perfusion. TRANS AM SOC ARTIF INTERN ORGANS 20: 299–305, 1974.

    Google Scholar 

  71. Winchester JF, Forbes CD, Courtney JM, Prentice CRM: Effect of sulfinpyrazone and aspirin on platelet loss induced in vitro by activated charcoal hemoperfusion. THROMB HAEMOSTAS 38: 93, 1977.

    Google Scholar 

  72. Lindsay RM, Prentice CRM, Kennedy AC, McNicol GP: Studies on thrombus formation and prevention within haemodialysers. BR J HAEMATOL 22: 640–641, 1972.

    PubMed  CAS  Google Scholar 

  73. Lindsay RM, Prentice CRM, Ferguson D, Burton JA, McNichol GP: Reduction of thrombus formation of dialyser membranes by aspirin and RA 233. LANCET 2: 1287–1290, 1972.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Harvard Medical School and Beth Israel Hospital, Boston, MA, USA

    Edwin W. Salzman M.D.

Authors
  1. Edwin W. Salzman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Section of Hematology, Temple University, Health Sciences Center, 19140, Philadelphia, PA, USA

    H. James Day M.D.

  2. Diabetes and Atherosclerosis Research, The Upjohn Company, 49001, Kalamazoo, MI, USA

    Basil A. Molony M.D. , Edward E. Nishizawa Ph.D.  & Ronald H. Rynbrandt Ph.D. ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer Science+Business Media New York

About this chapter

Cite this chapter

Salzman, E.W. (1978). Influence of Antiplatelet Drugs on Platelet-Surface Interactions. In: Day, H.J., Molony, B.A., Nishizawa, E.E., Rynbrandt, R.H. (eds) Thrombosis. Advances in Experimental Medicine and Biology, vol 102. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1217-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1217-9_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1219-3

  • Online ISBN: 978-1-4757-1217-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation